Biocon - Testing Support
Updated
A break below may open targets of 380 if not beyond, specially if Pharma continues its consolidation
Note
Buy above 403
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.